Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation

被引:109
|
作者
Frick, M [1 ]
Frykman, V
Jensen-Urstad, M
Östergren, J
Rosenqvist, M
机构
[1] South Hosp, Dept Cardiol, S-11883 Stockholm, Sweden
[2] Karolinska Hosp, Dept Cardiol, S-10401 Stockholm, Sweden
[3] Karolinska Hosp, Dept Med, S-10401 Stockholm, Sweden
关键词
atrial fibrillation; cardioversion; arrhythmias;
D O I
10.1002/clc.4960240313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The recurrence rate of atrial fibrillation (AF) after elective cardioversion is high. Hypothesis: The study aimed to identify clinical predictors for successful electrical cardioversion and maintenance of sinus rhythm after a first electrical cardioversion in patients with persistent AF without concomitant antiarrhythmic drugs of class I and LII. Methods: Consecutive outpatients (n = 166) with persistent AF for > 1 month, scheduled for elective cardioversion, were prospectively included in the study. A clinical investigation, echocardiographic assay, and Kelter electrocardiogram (ECG) before and ECG 4 weeks after cardioversion, were performed in all patients. Results: The mean age of the patients was 68 years (range 45-83) and duration of AF was 5 (1-48) months. Sinus rhythm was established in 124 (75%) patients. In multivariate analysis, only duration of AF < 6 months (p < 0.04, odds ratio [OR] 2.2, 95% confidence interval [CI] 1.1 to 4.7) and patients weight (p <0.03, OR 2.3, 95% CI 1.1 to 4.8 for weight < 80 kg) were identified as independent predictors of successful cardioversion. At 4 weeks after cardioversion, only 46 (37%) of 124 patients maintained sinus rhythm. Independent factors for maintenance of sinus rhythm, in multivariate analysis, were AF <3 months (p<0.04, OR 2.5, 95% CI 1.1 to 5.6), treatment with beta blockers (p < 0.00001, OR 7.0, 95% CI 3.0 to 16.3) or verapamil/diltiazem (p<0.04, OR 3.6, 95% CI 1.1 to 12.1), and right atrial dimension < 37 mm (p < 0.02, OR 5.9, 95% CI 1.4 to 25.4). Conclusions: In patients with persistent AF, the patient's weight and the duration of AF are independent predictors for a successful cardioversion. Short duration of AF, treatment with beta blockers or verapamil/diltiazem, and right atrial area/dimension are independent predictors for maintenance of sinus rhythm.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 50 条
  • [41] Left atrial volume predicts recurrence of nonvalvular atrial fibrillation after electrical cardioversion
    Marchese, P.
    Delle Donne, G.
    Bursi, F.
    Malavasi, V.
    Barbieri, A.
    Casali, E.
    Modena, M. G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 541 - 541
  • [42] Noninvasive Recurrence Quantification Analysis Predicts Atrial Fibrillation Recurrence in Persistent Patients Undergoing Electrical Cardioversion
    Meste, Olivier
    Zeemering, Stef
    Karel, Joel
    Lankveld, Theo
    Schotten, Ulrich
    Crijns, Harry
    Peeters, Ralf
    Bonizzi, Pietro
    2016 COMPUTING IN CARDIOLOGY CONFERENCE (CINC), VOL 43, 2016, 43 : 677 - 680
  • [43] Frequency of symptomatic recurrence of atrial fibrillation after successful electrical cardioversion of atrial fibrillation in patients treated with metoprolol in comparison to sotalol
    Fischer, F
    Schwacke, H
    Rameken, M
    Vater, M
    Seidl, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 93A - 93A
  • [44] Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion
    Siu, CW
    Lau, CP
    Tse, HF
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (11): : 1343 - 1345
  • [45] ELECTRICAL CARDIOVERSION FOR PERSISTENT ATRIAL-FIBRILLATION AFTER TREATMENT OF THYROTOXICOSIS
    EMERY, P
    STAFFURTH, JS
    POSTGRADUATE MEDICAL JOURNAL, 1982, 58 (686) : 746 - 748
  • [46] Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation
    Walek, Pawel
    Ciesla, Elzbieta
    Gorczyca, Iwona
    Wozakowska-Kaplon, Beata
    MEDICINE, 2020, 99 (49) : E23333
  • [47] Dabigatran to reduce recurrence of atrial fibrillation after successful electrical cardioversion
    Obst, C.
    Roithinger, F. X.
    Fiedler, L.
    Schoenbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S62 - S63
  • [48] Dabigatran to reduce recurrence of atrial fibrillation after successful electrical cardioversion
    Obst, C.
    Roithinger, F. X.
    Fiedler, L.
    Schoenbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S62 - S63
  • [49] Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion
    Garcia-Fernandez, Amaya
    Marin, Francisco
    Mainar, Luis
    Roldan, Vanessa
    Martinez, Juan G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (09): : 1299 - 1300
  • [50] A New Electrocardiographic Marker for Recurrence of Atrial Fibrillation After Electrical Cardioversion
    Fujimoto, Yuhi
    Yodogawa, Kenji
    Takahashi, Kenta
    Tsuboi, Ippei
    Yamamoto, Teppei
    Iwasaki, Yu-ki
    Hayashi, Meiso
    Shimizu, Wataru
    CIRCULATION, 2016, 134